Biogen
Clinical trials sponsored by Biogen, explained in plain language.
-
New MS drug trial for japanese patients shows promise but study stopped early
Disease control TerminatedThis study tested the drug natalizumab in 21 Japanese adults with relapsing-remitting multiple sclerosis (MS). The goal was to see if injections under the skin every 4 weeks could reduce new brain lesions over 24 weeks, and to check safety for up to 48 weeks. The study was termin…
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
ALS drug trial halted: what happened with BIIB105?
Disease control TerminatedThis study tested an experimental drug called BIIB105 in adults with ALS, a progressive nerve disease. The trial had two parts: a 6-month placebo-controlled phase and a 3-year open-label extension where everyone received the drug. The goal was to check safety, how the body proces…
Phase: PHASE1, PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC